جست‌وجوی استاد و پژوهشگر

Sathyanarayanan V Puthanveettilمشاهده پروفایل

دانشیار

• Molecular Neuroscience
• Memory Storage Mechanisms
• Synaptic Plasticity
• +۷ مورد دیگر

Sathyanarayanan V Puthanveettil is an Associate Professor in the Department of Neuroscience at the University of Florida College of Medicine, where he leads the SR-NEURO-PUTHANVEETTIL LAB. His academic journey includes significant research at Columbia University under Nobel laureate Eric Kandel, followed by positions at Scripps Research Institute and Florida Atlantic University. Dr. Puthanveettil's research focuses on the molecular and cellular basis of memory storage and cognitive disorders. His laboratory investigates the critical role of axonal transport in long-term memory formation, examining how organelles, proteins, mRNAs, and noncoding RNAs are transported to specific synapses. His integrated approach combines genomics, proteomics, electrophysiology, biochemistry, and advanced imaging techniques using model organisms like Aplysia and mice, including models of Alzheimer's and Huntington's disease. His publication record shows consistent high-impact output, with recent work focusing on RNA-mediated mechanisms of synaptic plasticity, kinesin motor proteins in memory formation, and mitochondrial transport in neurons. His research has evolved from foundational work on CPEB and synaptic plasticity to cutting-edge investigations of non-coding RNAs and their role in memory maintenance. CAREER Award from National Science Foundation (2015) Whitehall Foundation Award (2012) Young Investigator Award (2011) Searle Scholar Award nomination (2011) Recognition for work on Kinesin transported RNAs as 'HOT TOPIC' for Neuroscience (2009) Dr. Puthanveettil currently oversees multiple NIH-funded research projects totaling millions of dollars, with active grants from NIMH, NIA, NIGMS, and NIDA. His laboratory maintains collaborations across institutions and continues to train the next generation of neuroscientists. The Puthanveettil Lab utilizes advanced techniques to study how molecular transport coordinates nuclear and synaptic processes during memory storage, with significant implications for understanding and treating cognitive disorders.

Pavel Sumazinمشاهده پروفایل

استاد

• Computational Biology
• Genomics
• Molecular Profiling
• +۳ مورد دیگر

Pavel Sumazin is a Professor in the Department of Pediatrics at Baylor College of Medicine. He holds additional affiliations with the Dan L Duncan Comprehensive Cancer Center and the Quantitative and Computational Biosciences program at Baylor. His research focuses on computational and molecular analyses of cancer genomics, particularly in pediatric tumors. Major areas include non-coding RNA regulation, gene expression networks, and functional interpretation of genomic variants in cis and trans contexts. His work bridges computational biology with experimental validation to identify cancer driver genes and therapeutic targets. Recent publications highlight his expertise in lncRNA-target interactions, radiosensitivity prediction in pancreatic cancer, and innovative CAR T-cell therapies for solid tumors. His laboratory develops computational models for bulk RNA-Seq deconvolution and investigates metabolic vulnerabilities in neuroblastoma and leukemia. Prof. Sumazin's work has contributed to understanding tumor heterogeneity in hepatoblastoma, mechanisms of chemotherapy resistance in pediatric AML, and safety concerns in CRISPR/Cas9 gene therapy. His methodologies integrate machine learning with experimental validation for clinical applications.

Martin J. Müllerمشاهده پروفایل

استاد

• Plant lipid signalling
• Metabolomics and lipidomics
• Biotic and abiotic stress responses
• +۵ مورد دیگر

Prof. Dr. Martin J. Müller is Professor and Chair of Pharmaceutical Biology at the Julius von Sachs Institute of Biosciences, University of Würzburg, Germany. His group combines metabolomics, lipidomics and genetic approaches to decode lipid-mediated signalling in plants and insects under stress. Education & Career: 1992 Dissertation, Ludwig-Maximilian-University Munich 1993–present Continuous academic career culminating in appointment as Chair of Pharmaceutical Biology, University of Würzburg Research Focus: The Müller laboratory investigates how membrane-derived oxidised lipids (oxylipins, phytoprostanes, jasmonates) and energy-storage lipids (triacylglycerols) orchestrate plant adaptation to heat, salt, pathogens and herbivory. High-resolution mass spectrometry is employed to map metabolic shifts in Arabidopsis , crop plants and Drosophila , followed by CRISPR/Cas or classic mutant studies to test gene function. Recent work extends these concepts to the circadian clock, deciphering how daily oscillations in lipid metabolism couple to behavioural and physiological outputs in insects, and how natural variation across 1,135 Arabidopsis ecotypes underpins climate adaptation. Scientific Awards: While specific honours are not listed, Prof. Müller’s sustained funding record and >200 peer-reviewed articles (1993-2023) demonstrate international recognition. Research Teams & Collaboration: He heads the “AG Müller” research group and participates in collaborative centres including the CRC “Insect Timing” and the Metabolomics Core Unit. Ongoing projects integrate expertise from co-PIs Agnes Fekete, Daniel Maag and Arthur Korte.

• Signaling
• Genetics
• Hematopoiesis
• +۲ مورد دیگر

Adrienne M. Dorrance, PhD, serves as Associate Professor in the Division of Oncology at the University of Utah/Huntsman Cancer Institute, holding primary appointment in Internal Medicine and adjunct status in Oncological Sciences. Her research program bridges basic science and translational oncology with focus on hematopoietic malignancies. Her academic training includes a BSc and PhD from Ohio State University, followed by postdoctoral fellowships at Harvard Medical School/Children's Hospital Boston (Rac signaling in hematopoietic stem cells) and Ohio State University Comprehensive Cancer Center (leukemic stem cell mechanisms under Dr. Marcucci). BSc: Ohio State University PhD: Ohio State University College of Veterinary Medicine Postdoc I: Harvard Medical School Postdoc II: Ohio State University Comprehensive Cancer Center Dr. Dorrance's research centers on molecular drivers of acute myeloid leukemia, with expertise in signaling pathways (Rac, EGFL7, NOTCH), cancer stem cell biology, and bone marrow microenvironment interactions. Her seminal work demonstrates EGFL7's role in leukemic stem cell maintenance and as a therapeutic target across hematologic malignancies. She investigates genetic/epigenetic alterations in hematopoiesis and develops nanoparticle-based delivery systems for targeting microRNAs in leukemia stem cells. Analysis of her 15 most recent publications reveals dominant themes: leukemic stem cell regulation (73% of studies), microenvironmental interactions (60%), non-coding RNA biology (40%), and therapeutic targeting (87%). Key subfields include EGFL7 signaling (33%), bone marrow niche remodeling (27%), and metabolism-stemness connections (20%), reflecting her integrated approach to AML pathogenesis and treatment resistance. Dr. Dorrance maintains active NIH and American Cancer Society funding supporting her independent laboratory. She has mentored medical fellows, postdoctoral researchers, and graduate students while leading collaborative projects across hematology/oncology disciplines. Her laboratory at Huntsman Cancer Institute employs multidisciplinary approaches including murine transplantation models, single-cell genomics, and nanoparticle therapeutics development. Current efforts focus on translating EGFL7-targeting strategies into clinical applications and defining vascular niche contributions to treatment resistance in AML.

Donald Fraserمشاهده پروفایل

استاد

• Nephrology
• Chronic Kidney Disease
• Peritoneal Dialysis
• +۴ مورد دیگر

Professor Donald Fraser serves as Director of the Division of Infection and Immunity and Director of the Wales Kidney Research Unit within Cardiff University's School of Medicine. Clinically active as a consultant nephrologist at Cardiff and Vale University Health Board, he leads internationally recognized research on kidney injury mechanisms and fibrosis in chronic kidney disease and peritoneal dialysis contexts. His educational background includes an MB ChB from the University of Bristol (1993), membership in the Royal College of Physicians (1996), PhD from University of Wales College of Medicine (2003), and Certificate of Completion of Training in General Medicine and Nephrology (2006). Fraser's research program investigates fibro-proliferative disorders through multiple approaches: MicroRNA biomarker discovery for kidney disease progression Mechanisms of peritoneal membrane injury during dialysis Inflammatory pathways in renal scarring Translational models of kidney fibrosis His work bridges basic science with clinical applications, focusing on diagnostic tools and therapeutic targets for conditions with limited treatment options. Analysis of his 15 most recent publications reveals strong emphasis on molecular mechanisms of kidney injury (73%), biomarker development (60%), and translational models (47%), with increasing integration of single-cell technologies and machine learning approaches since 2021. Key recognitions include: Health and Care Research Wales Lead Researcher (2013) American Society of Nephrology Travel Scholarship (2011) Sir Jules Thorne Scholarship (2010) Clinician Scientist Fellowship (2005) Kidney Research UK Clinical Training Fellowship (2000) As an academic supervisor, Fraser currently leads one PhD student as principal supervisor and four as cosupervisor, having previously guided 12 doctoral candidates to completion. His research program receives consistent funding from Health and Care Research Wales and Kidney Research UK, with recent projects focusing on peritoneal dialysis outcomes and microRNA-based diagnostics. He directs the Wales Kidney Research Unit's All-Wales strategy for kidney disease research and co-leads the Division of Infection and Immunity's internationally cited research program spanning basic immunology to clinical applications in human health.

• Epidemiology
• Diagnostic Imaging
• Infectious Diseases
• +۵ مورد دیگر

Professor Tom Maddox is an active veterinary academic specializing in epidemiology, diagnostic imaging, and infectious diseases with emphasis on equine and canine clinical research. His work bridges orthopaedic surgery, antimicrobial resistance, and comparative anatomy, directly impacting veterinary clinical practice through evidence-based methodologies. His research program critically examines disease mechanisms in animals through advanced imaging and epidemiological approaches. Key areas include antimicrobial resistance in equine hospitals, breed-specific orthopaedic solutions for canines, and diagnostic imaging protocols for soft tissue and orthopaedic conditions. His focus on translational outcomes ensures clinical relevance across veterinary specialties. Recent publications (2024-2025) reveal strong trends in clinical veterinary science, particularly in pain management validation, osteoarthritis therapeutics, and cardiac/respiratory pathophysiology. The work consistently employs rigorous methodologies including randomized trials, longitudinal owner-reported data, and advanced imaging correlations, establishing new standards for canine and equine disease management. Identification of small non-coding RNAs in canine cranial cruciate ligament rupture as diagnostic and therapeutic targets (PET PLAN CHARITABLE TRUST: Oct 2021 - Apr 2024) Development of a medical device to support cell therapy delivery in surgery (MEDICAL RESEARCH COUNCIL: Jul 2016 - Sep 2017) Antimicrobial resistance in equines: Carriage and infections with multidrug resistant bacteria (THE HORSE TRUST: Aug 2016 - Oct 2021) Professor Maddox mentors doctoral candidates on anatomically stratified hip replacements, spinal stabilisation techniques, and antimicrobial resistance mechanisms. His teaching leadership includes coordinating advanced imaging modules covering orthopaedic and soft tissue diagnostics for small animals, directly translating research into veterinary education.

Douglas Blackمشاهده پروفایل

استاد

• RNA Processing
• Alternative Splicing
• Neurogenetics
• +۷ مورد دیگر

Douglas Black is a Professor in the Department of Microbiology, Immunology & Molecular Genetics at the University of California, Los Angeles (UCLA) , affiliated with the College of Life Sciences . He investigates RNA processing and alternative splicing , focusing on their roles in neuronal diversity and diseases like cancer and neurodegeneration. Research Focus : Regulation of pre-mRNA splicing, splicing regulators (PTBP1, PTBP2, RBFOX proteins), RNA biology, and transcriptomic impacts on health. Key Contributions : Elucidation of splicing mechanisms (e.g., SF3B1 mutations, LASR complex function) and therapeutic applications (splice-modifying drugs, RNA sensors). Recent Publications highlight mechanisms of splicing in cancer, neurodevelopment (RBFOX1/LASR), GBA1 mutations in neurodegeneration, and RNA localization (Malat1). Awards and education details were not explicitly mentioned.

Ledong Wanمشاهده پروفایل

استادیار

• RNA Splicing
• Pancreatic Cancer
• Inflammation
• +۴ مورد دیگر

Ledong Wan is an Assistant Professor at the Department of Pharmacological Sciences within Renaissance School of Medicine and the Cancer Center at Stony Brook University . His research focuses on RNA alternative splicing dysregulation in cancer, particularly pancreatic cancer and colorectal cancer , using transgenic mouse models and organoid cultures . The lab also explores small molecules and antisense technology for modulating aberrant splicing to develop cancer therapies. Research Interests: Dr. Wan’s work centers on understanding how RNA splicing becomes dysregulated in pancreatic and colorectal cancers , leading to tumor progression. His team investigates splicing factors like SRSF1 and SRSF6, their roles in inflammation , and therapeutic strategies targeting these mechanisms. Trends in Publications: His recent articles highlight RNA splicing in pancreatic ductal adenocarcinoma , colorectal cancer , and thyroid cancer . Key themes include splicing factors (SRSF1, RBM10), organoid-based drug screening , chronic stress effects on metastasis, and antisense oligonucleotides for splicing modulation.

Chengfeng Yangمشاهده پروفایل

استاد

• RNA dysfunction in carcinogenesis
• Cancer therapy resistance
• Non-coding RNAs
• +۵ مورد دیگر

Dr. Chengfeng Yang is a Professor in the Department of Pathology at the Renaissance School of Medicine, Stony Brook University. His research program focuses on Oncogenic Drivers and Mechanisms of Carcinogenesis, with particular emphasis on RNA dysfunction in cancer development and resistance to therapies. Dr. Yang received his medical degree from Tongji Medical University, completed his PhD at National University of Singapore, and conducted postdoctoral training at New York University and University of Pennsylvania. This diverse educational background has equipped him with expertise spanning medicine, molecular biology, and toxicology. His laboratory investigates the role and mechanism of RNA abnormal expression and post-transcriptional modifications in cancer initiation (carcinogenesis), progression (metastasis), and therapeutic resistance. The research is grounded in the recognition that human genome is pervasively transcribed, with a large portion transcribed as non-coding RNAs, especially long non-coding RNAs (lncRNAs). His work demonstrates how environmental carcinogens, particularly metals like hexavalent chromium and arsenic, dysregulate RNA molecules leading to cancer stem cell-like properties and tumorigenesis. Analysis of Dr. Yang's recent publication record reveals consistent productivity with expanding interdisciplinary connections, particularly between RNA biology, environmental toxicology, and microbiome research. His work bridges molecular biology, toxicology, and oncology, with significant focus on identifying dysfunctional RNA molecules as potential diagnostic markers and therapeutic targets for cancer prevention and treatment. Dr. Yang actively mentors undergraduate and graduate students in his laboratory, providing research opportunities to study the mechanisms of carcinogenesis. His laboratory serves as a hub for interdisciplinary cancer research at Stony Brook University, collaborating with researchers across multiple departments and institutions.

Jan Wilhelm Kornfeldمشاهده پروفایل

استاد

• Epigenetics
• Metabolism
• Non-coding RNA
• +۳ مورد دیگر

Jan Wilhelm Kornfeld is a Professor at the Department of Biochemistry and Molecular Biology, University of Southern Denmark, leading a research group focused on epigenetic regulation of energy metabolism in cardiometabolic diseases. After obtaining his PhD in Cell Biology from the Boltzmann Institute for Cancer Research (2008), he conducted postdoctoral research with Jens Brüning in Germany (2013), where he pioneered studies on obesity-associated microRNAs and hepatic insulin resistance. His independent research at CECAD (2013) and Max Planck Institute for Metabolism Research (2014) has been supported by prestigious grants including the Emmy-Noether Grant (2014) and ERC Starting Grant (2015). Education: PhD in Cell Biology, Boltzmann Institute for Cancer Research, Austria (2008) Postdoctoral Training, Jens Brüning Lab, Germany (2013) The Kornfeld Lab investigates epigenetic regulatory processes such as non-coding microRNAs (miRNA) and chromatin modifications that impact organismal, tissue, and cellular energy balance. Their research integrates molecular genomics , transgenic animal models , and inter-organ crosstalk to uncover disease-associated molecular signatures in obesity and type 2 diabetes (T2D). Key projects include miRNA perturbation in vivo, nutritional intervention strategies, and development of adeno-associated virus (AAV) gene therapy tools . Recent publications highlight work on dietary sulfur amino acid restriction , mitochondrial dysfunction in brown adipocytes, and miR-let-7 in intergenerational metabolic decline. His research spans transcriptional regulation , metabolomics , and non-coding RNA mechanisms in metabolic diseases. Scientific Awards: Emmy-Noether Grant (2014) ERC Starting Grant (2015) The lab actively trains Bachelor, Master, and ISA students in hypothesis-driven research, focusing on RNA-mediated gene regulation , chromatin dynamics , and (patho)physiological analysis . Collaborations with global experts and industrial partners enhance translational impact.

Gabriela Kaniaمشاهده پروفایل

پژوهشگر

• Systemic Sclerosis (SSc)
• Cardiovascular Diseases
• Pulmonary Diseases
• +۵ مورد دیگر

Gabriela Kania is a Professor of Medicine at the University of Zurich and a Research Group Leader at the Center for Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich (USZ), affiliated with the Bio-Technopark Schlieren. Her work focuses on systemic sclerosis (SSc), cardiovascular and pulmonary diseases, fibrosis, and fibroblast-macrophage interactions. 2022: Professorship, Faculty of Medicine, University of Zurich 2013–Present: Research Group Leader, Center for Experimental Rheumatology, USZ 2009–2013: Independent Research Associate, Experimental Intensive Care Medicine, University Hospital Basel 2005–2009: Postdoc, In Vitro Differentiation Group, IPK Gatersleben Her research integrates 3D cell/tissue cultures , single-cell analyses , animal models , monocyte/macrophage biology , and fibrosis mechanisms . Recent publications emphasize non-coding RNA regulation and TGF-β signaling in cardiac and SSc pathogenesis. Notable contributions include studies on TNF-α in myocarditis, HOTAIR in rheumatoid arthritis, and H19X in SSc endothelial dysfunction. She collaborates with institutions like the Zurich Center for Integrative Human Physiology (ZIHP) and Swiss Stem Cell Network.

• Neuroscience
• Epigenetics
• Cell Reprogramming
• +۴ مورد دیگر

Cheen Euong Ang is a Visiting Professor in the Department of Chemistry and Chemical Biology at Harvard University's Faculty of Arts and Sciences. Affiliated with the Zhuang Research Group, his work focuses on neuronal engineering, epigenetic regulation, and cellular reprogramming mechanisms. Department of Chemistry and Chemical Biology, Harvard University Zhuang Research Group, Faculty of Arts and Sciences His research spans neuroscience and epigenetics, with particular emphasis on: Direct neuronal reprogramming from somatic cells Epigenetic dynamics during cellular transitions Long non-coding RNA functions in brain development Matrix stiffness effects on chromatin states Neurodevelopmental disorder modeling Recent publications demonstrate expertise in: Neuronal differentiation using transcription factors Single-cell epigenomic profiling Transdifferentiation of immune cells to neurons Neurogenetic mechanisms in 22q11.2 deletion syndrome lncRNA-mediated pathogenic pathways

• RNA therapeutics
• Artificial Intelligence
• probabilistic model
• +۱۰ مورد دیگر

Michiaki Hamada is a Professor at Waseda University's Faculty of Science and Engineering, School of Advanced Science and Engineering. He also serves as President of the Japanese Society for Bioinformatics (since April 2024) and holds visiting positions at the National Institute of Advanced Industrial Science and Technology and Nippon Medical School's Graduate School of Medicine. His research laboratory focuses on bioinformatics with particular emphasis on functional RNA, epigenetics, and RNA drug discovery. Ph.D. in Science from Tokyo Institute of Technology (2009) Master's in Mathematics from Tohoku University (2002) Bachelor's in Mathematics from Tohoku University (2000) Professor Hamada's research spans multiple areas of bioinformatics, with particular focus on RNA biology, machine learning applications in sequence analysis, and computational approaches to drug discovery. His work bridges computational methodologies with biological applications, developing tools for RNA structure prediction, aptamer design, and genome analysis. His laboratory has made significant contributions to understanding RNA-protein interactions, transposable element biology, and the application of deep learning to RNA engineering problems. His recent publications demonstrate a strong focus on applying machine learning and deep learning techniques to RNA-related problems, including RNA aptamer generation, RNA structure prediction, and RNA therapeutic development. His research group has developed several computational tools like RaptGen for aptamer design, DeepRaccess for RNA accessibility prediction, and REPrise for repeat detection. His work shows a consistent pattern of developing computational methods with direct biological applications, particularly in the areas of RNA therapeutics and genome analysis. Okuma Memorial Academic Award (Encouragement Award) 2024.11 Waseda University Teaching Award 2023.07 Waseda University Next Generation Core Researchers 2022 Waseda University Research Award for International Research Dissemination 2021.12 MEXT Young Scientists' Award 2017.04 National Institute of Advanced Industrial Science and Technology President's Award (Research) 2016.04 As Principal Investigator, Professor Hamada has led numerous competitive research projects including multiple KAKENHI grants (Young Researcher, Challenging Exploratory Research, New Academic Fields), CREST programs, and industry collaborations. He actively contributes to the bioinformatics community through leadership roles, including serving as President of the Japanese Society for Bioinformatics and organizing joint symposia between Waseda University and Nippon Medical School. His laboratory maintains strong collaborations with both computational and experimental groups, facilitating the translation of computational methods into biological applications. Professor Hamada leads the Hamada Laboratory (hamadalab.com), which focuses on developing computational tools for RNA analysis and design. His group maintains active collaborations with researchers at Nippon Medical School, AIST, and other institutions, creating a strong interdisciplinary research environment. The laboratory has developed several widely-used bioinformatics tools and maintains an active publication record in high-impact journals across computational biology, genomics, and RNA research fields.

Johann Bauersachsمشاهده پروفایل

استاد

• Acute coronary syndromes
• Left ventricular healing and remodeling after ischemia
• Acute and chronic heart failure
• +۷ مورد دیگر

Prof. Dr. Johann Bauersachs is a distinguished German cardiologist, holding the position of Full Professor and Director of the Department of Cardiology and Angiology at Hannover Medical School (MHH) since 2010. Additionally, he serves as Managing Director of the Center for Internal Medicine at MHH since 2020. With board certifications in Internal Medicine, Cardiology, and Intensive Care Medicine, plus additional qualifications in Interventional Cardiology and Heart Failure, he brings extensive clinical expertise to his leadership roles. Prof. Bauersachs' research focuses on acute coronary syndromes, left ventricular healing and remodeling after ischemia, acute and chronic heart failure, and intensive care medicine. He has particular expertise in peripartum cardiomyopathy, aldosterone and mineralocorticoid receptor-mediated mechanisms, and the role of non-coding RNAs in cardiovascular disease. His laboratory investigates cellular and molecular mechanisms regulating infarct wound healing and cardiac remodeling after myocardial ischemia, with a major focus on elucidating the pathophysiological relevance of adrenocortical steroid receptors in myeloid cells. His publication record is exceptional with 1,133 publications, an H-Index of 107 (Web of Science), and recognition as a Highly Cited Researcher in Clinical Medicine. His research spans from basic science to clinical trials, including the DIGIT-HF study investigating digitoxin in advanced heart failure and the HF-REVERT trial examining CDR132L for post-MI heart failure. Oskar-Lapp Award, Deutsche Gesellschaft für Kardiologie (2001) Albert-Fraenkel-Award, Deutsche Gesellschaft für Kardiologie (2004) Parmley-Award, American College of Cardiology (2006) Bernard and Joan Marshall Distinguished Investigator Award (2012) Paul Morawitz-Award, Deutsche Gesellschaft für Kardiologie (2018) Honorary member of Corean and Romanian Societies of Cardiology ScholarGPS Highly Ranked Scholar (2022) Highly cited researcher in Clinical Medicine (2023) Prof. Bauersachs serves as Speaker of Clinical Research Group (KFO) 311 funded by the DFG, and as Study Director of the DIGIT-HF Study funded by BMBF. He has held significant leadership positions including Chair of the ESC Working Group on Myocardial Function, Member of the ESC Congress Programme Committee, and Board Member of the German Cardiac Society. As Deputy Editor of the European Heart Journal and Associate Editor of Cardiovascular Research, he plays a key role in shaping cardiovascular science. His laboratory provides robust research opportunities in cardiac wound healing, myocardial remodeling, and novel therapeutic approaches for heart disease.

• Lipidomics
• Metabolomics
• Inflammatory Bowel Disease (IBD)
• +۷ مورد دیگر

Lorena Ortega Moreno is an Assistant Professor in the Basic Health Sciences Department at King Juan Carlos University (URJC), Madrid, Spain. Her research focuses on the intersection of lipidomics, metabolomics, and inflammatory bowel disease (IBD) pathogenesis, with particular emphasis on biomarker discovery and gut-brain axis mechanisms. She leads the IMPULSO-URJC project investigating extracellular vesicles in colorectal cancer. Her research interests span: Lipidomics and metabolomics for biomarker discovery in gastrointestinal disorders Adipokine biology in inflammatory and metabolic diseases Long non-coding RNA roles in IBD pathogenesis and treatment response Extracellular vesicle characterization in colorectal cancer Gut-brain axis interactions in neurodegenerative conditions Her work integrates multi-omics approaches to identify non-invasive diagnostic tools and therapeutic targets for IBD and related conditions. Analysis of her 15 most recent publications reveals consistent focus on: IBD biomarker discovery through lncRNA, proteomic, and metabolomic profiling Translational applications of microbiome-derived compounds Metabolite signatures for disease stratification (COVID-19, diabetes complications) Cross-disease applications of lipidomics in neurodegeneration Her methodology emphasizes clinical validation of omics findings for diagnostic applications. Scientific recognition includes: Two Research Quinquennia (Sexenios de Investigación) awarded by ANECA in 2023 Extensive international collaboration network across Europe and US institutions Her advisory and grant portfolio demonstrates strong leadership in translational research: Principal Investigator for IMPULSO-URJC project on extracellular vesicles in colorectal cancer (2025) Recipient of Comunidad de Madrid Talent Attraction Grant (2018-2022) Previous Hearst Foundation postdoctoral fellowship at Joslin Diabetes Center She maintains active collaborations with Hospital Universitario La Princesa and international research groups. Her laboratory work centers on the Gut Immunology Research Lab, utilizing: Multi-omics platforms (lipidomics, metabolomics, proteomics) Extracellular vesicle isolation and characterization Translational animal models for gut-brain axis studies Clinical sample analysis from IBD and colorectal cancer cohorts Current efforts focus on developing non-invasive diagnostic tools for gastrointestinal disorders.